StockData
Evaxion A/S logo

Evaxion A/S (EVAX) stock

EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$2.78+0.01 (+0.36%)

Close on Nov 17, 2026Market cap $23.19MP/E –Yield –

Evaxion A/S cash

Cash and short-term investments held at the end of each period.

Evaxion A/S's cash was $14.00M at Jun 30, 2026. For fiscal 2025 it was $23.23M, up 290.4% from the year before. The highest annual figure on record is $32.17M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.23M+290.4%
FY2024Dec 31, 2024$5.95M+6.6%
FY2023Dec 31, 2023$5.58M-57.7%
FY2022Dec 31, 2022$13.18M-59.0%
FY2021Dec 31, 2021$32.17M+451.4%
FY2020Dec 31, 2020$5.83M-39.0%
FY2019Dec 31, 2019$9.56M+28.6%
FY2018Dec 31, 2018$7.43M+1488.2%
FY2017Dec 31, 2017$468.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.00M+75.2%
Q4 FY2025Dec 31, 2025$23.23M+316.2%
Q2 FY2025Jun 30, 2025$14.75M+107.2%
Q4 FY2024Dec 31, 2024$5.95M-54.9%
Q2 FY2024Jun 30, 2024$7.99M-68.3%
Q4 FY2023Dec 31, 2023$5.58M-82.2%
Q2 FY2023Jun 30, 2023$7.12M-77.9%
Q4 FY2022Dec 31, 2022$13.18M+10.4%
Q2 FY2022Jun 30, 2022$25.25M+34.3%
Q1 FY2022Mar 31, 2022$31.41M+16.5%
Q4 FY2021Dec 31, 2021$32.17M+451.4%
Q3 FY2021Sep 30, 2021$11.94M+51.7%
Q2 FY2021Jun 30, 2021$18.80M+360.2%
Q1 FY2021Mar 31, 2021$26.96M+324.8%
Q4 FY2020Dec 31, 2020$5.83M-39.0%
Q3 FY2020Sep 30, 2020$7.88M+5.9%
Q2 FY2020Jun 30, 2020$4.09M+772.9%
Q1 FY2020Mar 31, 2020$6.35M–
Q4 FY2019Dec 31, 2019$9.56M–
Q4 FY2018Dec 31, 2018$7.43M–
Q4 FY2017Dec 31, 2017$468.00K–

More Evaxion A/S figures

See a number that looks wrong?